Vactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma.
Clinical trial NCT04258072 · UNKNOWN
Trial details
- NCT number
- NCT04258072
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-19
- Primary completion
- 2022-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.